Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...
Our policy briefings and explainers are part of our horizon-scanning programme to identify those novel technologies showing greatest promise for health research and care. Succinct and accessible, they ...
Chantal is a Senior Policy Analyst contributing to many of PHG foundations projects including B-CAST, polygenic scores and Innovative Science. As a senior analyst she supports the science team in ...
AI and its potential impact on genomics research and clinical practice was peppered throughout this year's Festival of Genomics ...
Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...
We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...
‘While molecular biomarkers such as genetics have proved valuable in the management of many diseases, the dynamic information provided by many physiological biomarkers will complement, enhance and ...
In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...
Recent developments – at national and international levels – in the regulation and governance of data, AI and medical devices are having significant impacts and potential impacts on the application of ...